Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M

Stock Information for MicroVision Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MicroVision Inc.

Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream
Bioxytran's Groundbreaking Stroke & Alzheimer's Tech Gains Validation That Measures Oxygenation Uptake During Strokes
Bioxytran's Antiviral Breakthrough Featured in University of Georgia's $100M HPAI Poultry Innovation Grand Challenge Submission
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream
Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements
Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.